ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Rheumatology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,119Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 96

$898K Total Retail Price of All Prescriptions

Rank: 3 out of 96

435 Patients Receiving at Least One Drug in Part D
57%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 435 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

31% of this provider’s 435 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

3% of this provider’s 4,228 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$111 was the average price of a prescription from this provider, compared to $132 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
HYDROCODONE-ACETAMINOPHEN 952 371 S3 1 4
HYDROXYCHLOROQUINE SULFATE 464 305 2 3
METHOTREXATE 438 329 3 1
TRAZODONE HCL 374 142 4 28
TRAMADOL HCL 260 98 5 5
PREDNISONE 242 190 6 2
GABAPENTIN 227 40 7 6
FLUOXETINE HCL 219 87 8 51
CYCLOBENZAPRINE HCL 192 35 R 9 10
OXYCODONE HCL 191 37 S2 10 23
CYMBALTA 186 72 11 14
OMEPRAZOLE 157 105 12 12
ENALAPRIL MALEATE 139 113 13 60
ALENDRONATE SODIUM 124 77 14 7
FUROSEMIDE 112 95 15 32
ALLOPURINOL 105 89 16 8
SIMVASTATIN 105 89 16 19
OXYCONTIN 102 0 S2 18 48
LYRICA 98 19 19 26
LEVOTHYROXINE SODIUM 91 80 20 29
BUPROPION XL 86 0 21 88
EVISTA 83 82 22 90
ATORVASTATIN CALCIUM 83 73 22 52
AMITRIPTYLINE HCL 81 42 R 24 37
SERTRALINE HCL 80 50 25 41
LEFLUNOMIDE 76 26 26 13
FENTANYL 74 26 S2 27 44
ENBREL 70 41 28 11
METFORMIN HCL 68 41 29 35
MIRTAZAPINE 66 0 30 63
SAVELLA 60 0 31 71
SULFAZINE EC 58 42 32 64
CITALOPRAM HBR 57 28 33 43
MELOXICAM 56 39 34 9
MORPHINE SULFATE ER 54 0 S2 35 56
CARISOPRODOL 53 0 R 36 75
HUMIRA 52 0 37 22
OXYCODONE-ACETAMINOPHEN 50 0 S2 38 21
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 11, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.